Food fortification in psm
food fortification PSM Park's preventive social medicine iodine iron vitamin A fluoride
| Programme | Vehicle | Nutrient Added | Target Condition |
|---|---|---|---|
| Fluoridation of water | Water | Fluoride | Dental caries |
| Iodization of salt | Common salt | Iodine | Endemic goitre / IDD |
| Vanaspati/milk fortification | Vanaspati, milk | Vitamins A & D | Vitamin A deficiency, rickets |
| Twin fortification of salt | Common salt | Iodine + Iron | IDD + anaemia |
| Type | Description | Example |
|---|---|---|
| Mass / Large-scale fortification | Nutrients added to foods consumed by the general population | Iodized salt, fluoridated water |
| Targeted fortification | For specific at-risk groups (children, pregnant women) | Iron-fortified infant formula, folic acid in flour for women of reproductive age |
| Point-of-use fortification | Micronutrient powders added just before consumption (at home/school) | Sprinkles for complementary feeding |
| Strategy | Approach | Best For |
|---|---|---|
| Fortification | Add nutrients to foods | Population-wide, long-term prevention |
| Supplementation | Give high-dose nutrient pills/drops | Severe deficiency, targeted groups (e.g., Vitamin A megadose) |
| Dietary diversification | Improve variety and quality of diet | Sustainable community-level change |
Botulism in psm
| Type | Mechanism | Example |
|---|---|---|
| Infection type | Ingestion of viable organisms that multiply in gut | Salmonella, Shigella |
| Toxin type (Intoxication) | Toxins produced by organisms in food | Staphylococcus enterotoxin |
| Botulism | Ingestion of preformed botulinum toxin in preserved food | Clostridium botulinum |
| Type | Incubation Period |
|---|---|
| Food-borne botulism | 18-36 hours (Park's); range 6 hours to 10 days |
| Infant botulism | 3-30 days from ingestion of spores |
| Wound botulism | 4-14 days from time of injury |
| Type | Mechanism | Key Feature |
|---|---|---|
| Food-borne | Ingestion of preformed toxin in improperly preserved food | Most common PSM type; home-canned foods |
| Infant botulism | Spores ingested → germinate in gut → produce toxin in vivo | Most common type globally; honey a source; constipation is early sign |
| Wound botulism | C. botulinum infects traumatized tissue, produces toxin locally | Associated with crush injuries, "skin popping" of heroin |
| Iatrogenic/Bioterrorism | Botulinum toxin is a potential bioterrorism agent | Abrupt onset of neurological symptoms |
| Measure | Details |
|---|---|
| Heat food properly | Toxin is thermolabile - heating food at 100°C for a few minutes before use makes it safe (destroys preformed toxin) |
| Proper canning/preservation | Commercial canning (autoclaving at 121°C) destroys spores |
| Avoid low-acid home-preserved foods if improperly processed | Home-canned vegetables, pickled fish especially risky |
| Do not give honey to infants < 1 year | Spores in honey cause infant botulism |
| Antitoxin prophylaxis | Given to all who consumed the implicated food |
| Botulinum toxoid | For active immunization in high-risk groups |
Key point: The toxin is thermolabile - destroyed at 100°C for a few minutes. However, the spores are heat-resistant and require autoclaving (121°C, 15 min) for destruction.
| Feature | Staphylococcal | Salmonella | Botulism |
|---|---|---|---|
| Type | Intoxication | Infection | Intoxication |
| Incubation | 1-6 hours | 12-24 hours | 18-36 hours |
| Fever | Absent | Present | Absent |
| GI symptoms | Prominent (vomiting) | Prominent (diarrhoea) | Very slight |
| Nervous system | No | No | Prominent |
| Consciousness | Retained | Retained | Retained |
| Mortality | Low | Low | Very high |
Reasons of paralysis of muscle
Motor Cortex (UMN)
↓
Internal Capsule / Corticospinal Tract
↓
Spinal Cord (UMN ends / LMN begins at anterior horn)
↓
Anterior Horn Cell (LMN cell body)
↓
Peripheral Nerve (LMN axon)
↓
Neuromuscular Junction (NMJ)
↓
Muscle Fibre
| Feature | Finding |
|---|---|
| Weakness | Yes |
| Muscle atrophy | Minimal (disuse only) |
| Fasciculations | Absent |
| Tone | Increased (spasticity) |
| Reflexes | Hyperreflexia |
| Plantar response | Extensor (Babinski's sign +) |
| Clonus | Present |
Note: In acute UMN lesions (e.g., stroke, spinal shock), initial presentation is flaccid with decreased tone and reflexes - spasticity develops over hours to weeks.
| Feature | Finding |
|---|---|
| Weakness | Yes |
| Muscle atrophy | Prominent (early) |
| Fasciculations | Present |
| Tone | Decreased (flaccidity) |
| Reflexes | Hyporeflexia / areflexia |
| Plantar response | Flexor (normal) |
| Disorder | Mechanism | Key Feature |
|---|---|---|
| Myasthenia Gravis | Autoantibodies against ACh receptors (or MuSK) → postsynaptic failure | Fatigable weakness; worse with activity, better with rest; ptosis/diplopia |
| Lambert-Eaton Myasthenic Syndrome (LEMS) | Autoantibodies against presynaptic VGCC → reduced ACh release | Proximal weakness improves transiently with repeated stimulation; associated with lung cancer |
| Botulism | Botulinum toxin blocks presynaptic ACh release | Descending flaccid paralysis; diplopia, dysphagia, no fever |
| Organophosphate poisoning | Inhibits acetylcholinesterase → ACh accumulates | Cholinergic crisis; later paralysis |
| Succinylcholine / neuromuscular blockers | Competitive or depolarizing blockade of ACh receptor | Iatrogenic (used in anaesthesia) |
| Congenital myasthenic syndromes | Genetic defects in NMJ proteins | Present in infancy |
| Tick paralysis | Tick salivary toxin blocks presynaptic ACh | Ascending flaccid paralysis; resolves after tick removal |
| Category | Examples |
|---|---|
| Muscular dystrophies | Duchenne MD (dystrophin gene deletion), Becker MD, Fascioscapulohumeral dystrophy, Limb-girdle dystrophy |
| Inflammatory myopathies | Polymyositis, Dermatomyositis, Inclusion body myositis |
| Metabolic myopathies | McArdle's disease (glycogen storage), Mitochondrial myopathies |
| Channelopathies (periodic paralysis) | Hypokalemic periodic paralysis, Hyperkalemic periodic paralysis - ion channel mutations causing episodic weakness |
| Endocrine myopathies | Hypothyroid myopathy, Cushing's syndrome (steroid myopathy), Thyrotoxic myopathy |
| Toxic myopathies | Statins (rhabdomyolysis), Alcohol, Corticosteroids |
| Congenital myopathies | Nemaline myopathy, Central core disease, Centronuclear myopathy |
| Infectious myositis | Viral myositis (influenza), pyomyositis, trichinosis |
| Pattern | Lesion Location |
|---|---|
| Monoplegia (one limb) | Contralateral cortex (parasagittal) or ipsilateral cord/root |
| Hemiplegia (arm + leg, same side) | Contralateral cortex, internal capsule, brainstem |
| Paraplegia (both legs) | Thoracic/lumbar spinal cord, bilateral cortex (parasagittal) |
| Quadriplegia/Tetraplegia | Cervical spinal cord or bilateral hemispheres |
| Crossed hemiplegia (ipsilateral CN palsy + contralateral body) | Brainstem |
| Ascending paralysis | GBS, transverse myelitis |
| Descending paralysis | Botulism |
| Proximal > distal weakness | Myopathy, LEMS |
| Distal > proximal weakness | Neuropathy, Charcot-Marie-Tooth |
| Fatigable weakness | Myasthenia Gravis (NMJ) |
| Episodic weakness | Periodic paralysis (channelopathy) |
| Feature | UMN | LMN | NMJ | Myopathy |
|---|---|---|---|---|
| Tone | Increased (spastic) | Decreased (flaccid) | Normal | Normal/decreased |
| Reflexes | Increased | Decreased/absent | Normal | Normal/slightly reduced |
| Fasciculations | Absent | Present | Absent | Absent |
| Atrophy | Minimal | Prominent | Absent | Variable |
| Babinski | Present | Absent | Absent | Absent |
| Weakness distribution | Contralateral, pyramidal | Segmental/nerve territory | Proximal/ocular | Proximal |
| EMG | UMN pattern | Denervation | Decrement (MG) / Increment (LEMS) | Myopathic |
Icds in psm
| Area | Administrative Unit | Population Covered |
|---|---|---|
| Rural areas | Community Development Block | ~1,00,000 |
| Tribal areas | Tribal Development Block | ~35,000 |
| Urban areas | Group of slums | - |
| Beneficiary Group | Age |
|---|---|
| Children | 0-6 years |
| Pregnant women | - |
| Nursing (lactating) mothers | - |
| Other women | 15-45 years |
| Adolescent girls | 11-18 years |
Note: Below Poverty Line (BPL) is NOT a criterion - the scheme is universal.
| S.No. | Service |
|---|---|
| 1 | Supplementary Nutrition |
| 2 | Immunization |
| 3 | Health Check-up |
| 4 | Medical Referral Services |
| 5 | Nutrition and Health Education |
| 6 | Non-formal Pre-school Education (children up to 6 years) |
Services 2, 3, and 4 (immunization, health check-up, referral) are provided through public health infrastructure - sub-centres, PHC, and CHC.
| Beneficiary | Services |
|---|---|
| Pregnant women | Health check-up, Tetanus immunization, Supplementary nutrition, Nutrition & health education |
| Nursing mothers | Health check-up, Supplementary nutrition, Nutrition & health education |
| Other women (15-45 yrs) | Nutrition and health education only |
| Children < 3 years | Supplementary nutrition, Immunization, Health check-up, Referral services |
| Children 3-6 years | Supplementary nutrition, Immunization, Health check-up, Referral services, Non-formal pre-school education |
| Adolescent girls (11-18 yrs) | Supplementary nutrition, Nutrition and health education |
| Beneficiary | Calories | Protein |
|---|---|---|
| Child 6-72 months (normal) | 500 kcal | 12-15 g |
| Severely malnourished child 6-72 months | 800 kcal | 20-25 g |
| Pregnant / nursing woman | 600 kcal | 18-20 g |
| Functionary | Role |
|---|---|
| Anganwadi Worker (AWW) | Focal point for service delivery; selected from community; trained for 4 months; paid honorarium Rs. 1500/month; covers population of 400-800 |
| Child Development Project Officer (CDPO) | In-charge of each ICDS project; supervises 4 Supervisors and 100 AWWs |
| Supervisor (Mukhya Sevika) | Each responsible for 20-25 anganwadis; mentors AWWs; assists in record-keeping; provides on-the-job training |
| Mahila Mandals | Network of women's groups built up in ICDS areas to help AWWs |
| Target | Reduction |
|---|---|
| Stunting in children (0-6 yrs) | Reduce by 6% (2%/year) |
| Undernutrition/underweight in children (0-6 yrs) | Reduce by 6% (2%/year) |
| Anaemia in children (6-59 months) | Reduce by set targets |
| Low birth weight | Reduce by set targets |
| Item | Number |
|---|---|
| Year started | 1975 |
| Beneficiary age (children) | 0-6 years |
| Adolescent girls | 11-18 years |
| Other women | 15-45 years |
| AWC population coverage | 300-800 |
| Mini-AWC population | 150-300 |
| AWWs per ICDS project | ~100 |
| Supervisors per CDPO | 4 |
| AWCs per Supervisor | 20-25 |
| AWW training duration | 4 months |
| Supplementary nutrition days/year | 300 days |
| Calories for child (6-72 months) | 500 kcal + 12-15 g protein |
| Calories for severely malnourished child | 800 kcal + 20-25 g protein |
| Calories for pregnant/lactating mother | 600 kcal + 18-20 g protein |
| Weighing of children | Every month |
| Immunization for children | 9 vaccine-preventable diseases |
| Total ICDS projects (2019) | ~7,075 |
| Total AWCs functional (2019) | ~13.77 lakh |
Poshan abhiyan in psm
Poshan Abhiyan 2.0 PSM features objectives life cycle approach India nutrition mission
| S.No. | Target | Reduction | Rate |
|---|---|---|---|
| 1 | Prevent and reduce stunting in children (0-6 years) | By 6% | 2% per year |
| 2 | Prevent and reduce undernutrition/underweight in children (0-6 years) | By 6% | 2% per year |
| 3 | Reduce prevalence of anaemia among children (6-59 months) | By 9% | 3% per year |
| 4 | Reduce prevalence of anaemia among girls and women (15-49 years) | By 9% | 3% per year |
| 5 | Reduce Low Birth Weight (LBW) | By 6% | 2% per year |
Memory aid: Targets 1, 2, 5 = 6% total (2%/year); Targets 3, 4 = 9% total (3%/year)
Pre-pregnancy / Adolescent girl
↓
Pregnant woman (especially first 1,000 days - conception to 2 years)
↓
Lactating mother / Newborn
↓
Child under 6 years (pre-school)
↓
School-age child / Adolescent
| Programme | Ministry |
|---|---|
| Anganwadi Services (ICDS) | MoWCD |
| Pradhan Mantri Matru Vandana Yojana (PMMVY) | MoWCD |
| Schemes for Adolescent Girls (SABLA) | MoWCD |
| Janani Suraksha Yojana (JSY) | Ministry of Health & Family Welfare |
| National Health Mission (NHM) | Ministry of Health & Family Welfare |
| Swachh Bharat Mission | Ministry of Jal Shakti |
| Indicator | Figure |
|---|---|
| ICDS projects functional | ~7,075 |
| Anganwadi Centres / Mini-AWCs functional | 13.77 lakh |
| Pre-school education beneficiaries (children) | 305.09 lakh |
| Supplementary nutrition beneficiaries (children + PLMs) | 836.25 lakh |
| Feature | Details |
|---|---|
| Type of programme | Preventive + Promotive + Developmental |
| Level of care | Primary (village/AWC level) |
| Approach | Life cycle + convergence + technology + community participation |
| Key beneficiaries | 0-6 yr children, adolescent girls, pregnant & lactating mothers |
| Frontline worker | Anganwadi Worker (AWW) |
| Monitoring tool | Poshan Tracker App |
| Awareness month | Poshan Maah = September |
| Item | Value |
|---|---|
| Launch date | 18 Dec 2017 / 8 Mar 2018 |
| Duration | 3 years (2017-18 to 2020-21) |
| States/UTs covered | 36 |
| Stunting reduction target | 6% total (2%/year) |
| Underweight reduction target | 6% total (2%/year) |
| Anaemia reduction target (children 6-59 m) | 9% total (3%/year) |
| Anaemia reduction target (women 15-49 yrs) | 9% total (3%/year) |
| LBW reduction target | 6% total (2%/year) |
| Approach | Life cycle approach |
| Monitoring app | Poshan Tracker |
| Awareness campaign | Poshan Maah (September) |
Mid day meal scheme
PM POSHAN scheme mid day meal renamed 2021 features calorie norms India PSM
| Version | Name | Year |
|---|---|---|
| Original | Mid-Day Meal Programme (MDMP) / School Lunch Programme | Since 1961 |
| Centrally Sponsored Scheme | National Programme of Nutritional Support to Primary Education (NP-NSPE) | Launched 15th August 1995 |
| Renamed | National Programme of Mid-Day Meal in Schools | October 2007 |
| Current Name | PM POSHAN (Pradhan Mantri Poshan Shakti Nirman) | September 2021 |
| Year | Event |
|---|---|
| 1961 | Mid-day meal programme started throughout India |
| 5th Five Year Plan | Programme became part of Minimum Needs Programme |
| 15th August 1995 | Relaunched as centrally sponsored scheme (NP-NSPE) |
| 1997-98 | Covered whole country in phased manner (started in 2,408 blocks in 1st year) |
| October 2002 | Extended to Education Guarantee Scheme and Alternative & Innovative Education Centres |
| 2004 | Revised |
| October 2007 | Renamed National Programme of Mid-Day Meal in Schools |
| September 2021 | Renamed PM POSHAN (Pradhan Mantri Poshan Shakti Nirman) |
| Component | Amount |
|---|---|
| Food grain (central assistance) | 100 g per student per day (from nearest FCI godown) |
| Calories | Minimum 300 kcal |
| Protein | 8-12 g |
| Class | Calories | Protein |
|---|---|---|
| Primary (Classes I-V) | 450 kcal | 12 g |
| Upper Primary (Classes VI-VIII) | 700 kcal | 20 g |
Park's key principle: The meal should supply at least one-third of total energy requirement and half of protein need of the child.
| Foodstuff | Amount (g/day/child) |
|---|---|
| Cereals and millets | 75 g |
| Pulses | 30 g |
| Oils and fats | 8 g |
| Leafy vegetables | 30 g |
| Non-leafy vegetables | 30 g |
| Benefit | Details |
|---|---|
| Increased school enrolment | Particularly for girls and disadvantaged groups |
| Improved attendance and retention | Children come to school for the meal |
| Reduced classroom hunger | Improves concentration and learning |
| Nutritional improvement | Addresses protein-energy malnutrition |
| Social equity | Children of all castes eat together (promotes social cohesion) |
| Employment | Creates livelihood for cook-cum-helpers (mainly women) |
| Item | Value |
|---|---|
| Original start year | 1961 |
| Centrally sponsored launch | 15th August 1995 |
| Current name | PM POSHAN (Sep 2021) |
| Beneficiaries | >11 crore children |
| Schools covered | >11 lakh |
| Feeding days per year (NIN recommendation) | 250 days |
| Food grain per child per day | 100 g |
| Calories - Primary (I-V) | 450 kcal (Park's original: 300 kcal) |
| Calories - Upper Primary (VI-VIII) | 700 kcal |
| Protein - Primary | 12 g |
| Protein - Upper Primary | 20 g |
| Cereal:pulse ratio | 3:1 to 5:1 |
| One-third energy + half protein rule | Principle (b) of formulation |
| Model recipes by | NIN Hyderabad |
| Cost sharing | Centre 60% : State 40% |
Ors with example of appropriate technology in psm
"Technology that is scientifically sound, adaptable to local needs, and acceptable to those who apply it and those for whom it is used, and that can be maintained by the people themselves in keeping with the principle of self-reliance with the resources the community and country can afford."
| Generation | Composition | Notes |
|---|---|---|
| 1st (original) | Sodium bicarbonate-based | Less stable |
| 2nd | Trisodium citrate replaced sodium bicarbonate | More stable; less stool output in cholera |
| 3rd (current - Reduced Osmolarity ORS) | Reduced glucose + NaCl concentration | Lower osmolarity (245 mOsm/L); better efficacy |
| Ingredient | g/litre |
|---|---|
| Sodium chloride | 2.6 g |
| Glucose, anhydrous | 13.5 g |
| Potassium chloride | 1.5 g |
| Trisodium citrate, dihydrate | 2.9 g |
| Total weight | 20.5 g |
| Component | mmol/litre |
|---|---|
| Sodium (Na⁺) | 75 |
| Chloride (Cl⁻) | 65 |
| Glucose, anhydrous | 75 |
| Potassium (K⁺) | 20 |
| Citrate | 10 |
| Total osmolarity | 245 mOsm/L |
Compare: Standard/old ORS had osmolarity of 311 mOsm/L (Na 90 mmol/L); the reduced osmolarity version has 245 mOsm/L (Na 75 mmol/L)
| Sign | Mild Dehydration | Severe Dehydration |
|---|---|---|
| Appearance | Thirsty, alert, restless | Drowsy, limp, cold, sweaty; may be comatose |
| Radial pulse | Normal rate and volume | Rapid, feeble, sometimes impalpable |
| Blood pressure | Normal | < 80 mmHg; may be unrecordable |
| Skin elasticity (pinch) | Retracts immediately | Retracts very slowly (>2 seconds) |
| Tongue | Moist | Very dry |
| Anterior fontanelle | Normal | Very sunken |
| Urine flow | Normal | Little or none |
| % body weight lost | 4-5% | 10% or more |
| Estimated fluid deficit | 40-50 ml/kg | 100-110 ml/kg |
| Age | Weight | ORS volume in 4 hours |
|---|---|---|
| Under 4 months | < 5 kg | 200-400 ml |
| 4-11 months | 5-7.9 kg | 400-600 ml |
| 12-23 months | 8-10.9 kg | 600-800 ml |
| 2-4 years | 11-15.9 kg | 800-1200 ml |
| 5-14 years | 16-29.9 kg | 1200-2200 ml |
| 15 years and above | 30 kg or more | 2200-4000 ml |
| Criterion of Appropriate Technology | How ORS Fulfils It |
|---|---|
| Scientifically sound | Based on glucose-Na co-transport; proven to treat 90-95% diarrhoea/cholera cases |
| Adaptable to local needs | Used in hospitals, PHCs, sub-centres, and homes |
| Acceptable to users | Administered by mothers and community workers; no special training needed |
| Maintainable by people themselves | Home preparation with salt + sugar + water |
| Affordable | Low-cost ingredients; free at PHCs, sub-centres |
| Self-reliance | Reduces dependence on IV fluids and hospitals |
| Reduced mortality | Major breakthrough in reducing deaths from diarrhoeal diseases |
| Empowers community | Mothers can treat children at home |
"The introduction of oral rehydration fluid has not only reduced the cost of treatment, but also made possible treatment of patients in their own homes by primary health workers or relatives of patient." - Park's PSM
| Item | Value |
|---|---|
| % cholera/diarrhoea treatable by ORS alone | 90-95% |
| ORS total osmolarity (current - reduced) | 245 mOsm/L |
| ORS total osmolarity (old standard) | 311 mOsm/L |
| Sodium in reduced ORS | 75 mmol/L |
| Total weight of ORS per litre | 20.5 g |
| NaCl in ORS | 2.6 g/L |
| Glucose in ORS | 13.5 g/L |
| KCl in ORS | 1.5 g/L |
| Trisodium citrate in ORS | 2.9 g/L |
| Reduction in need for IV therapy with new ORS | 33% |
| Reduction in stool output | 20% |
| Reduction in vomiting | 30% |
| Home ORS (sugar-salt): salt | 1 level teaspoon |
| Home ORS (sugar-salt): sugar | 6 level teaspoons |
| Water for ORS preparation | 1 litre |
| ORS shelf life after preparation | 24 hours |
| IV fluid dose for severe dehydration | 100 ml/kg |
| India launched new ORS formulation | June 2004 (first country in world) |
| UNICEF procures only new ORS since | January 2004 |
Bmi in psm
| Classification | BMI (kg/m²) | Risk of Comorbidities |
|---|---|---|
| Underweight | < 18.50 | Low (but risk of other clinical problems increased) |
| Normal range | 18.50 - 24.99 | Average |
| Overweight | ≥ 25.00 | - |
| - Pre-obese | 25.00 - 29.99 | Increased |
| - Obese Class I | 30.00 - 34.99 | Moderate |
| - Obese Class II | 35.00 - 39.99 | Severe |
| - Obese Class III (Morbid obesity) | ≥ 40.00 | Very severe |
- BMI values are age-independent and the same for both sexes
- The WHO classification is based primarily on the association between BMI and mortality
- The risks associated with increasing BMI are continuous and graded and begin at a BMI above 25
| Grade | BMI |
|---|---|
| Grade I CED (Mild) | 17.0 - 18.49 |
| Grade II CED (Moderate) | 16.0 - 16.99 |
| Grade III CED (Severe) | < 16.0 |
| Classification | WHO (Global) | Asian / Indian Cut-off |
|---|---|---|
| Normal | 18.5 - 24.99 | 18.5 - 22.9 |
| Overweight (risk) | ≥ 25.0 | ≥ 23.0 |
| Obesity | ≥ 30.0 | ≥ 27.5 |
| Index | Formula |
|---|---|
| (1) BMI (Quetelet's Index) | Weight (kg) / Height² (m) |
| (2) Ponderal Index | Height (cm) / ∛Body weight (kg) |
| (3) Brocca Index | Height (cm) - 100 = ideal weight in kg |
| (4) Lorentz Formula | Ht(cm) - 100 - [Ht(cm) - 150] / 2 (women) or 4 (men) |
| (5) Corpulence Index | Actual weight / Desirable weight (should not exceed 1.2) |
The BMI and Brocca index are most widely used. A FAO/WHO/UNU report gives reference tables for BMI usable internationally.
| Men | Women | |
|---|---|---|
| Waist circumference | ≥ 102 cm | ≥ 88 cm |
| Waist:Hip Ratio (WHR) | > 1.0 | > 0.85 |
| Risk Level | Conditions |
|---|---|
| Greatly increased | Type 2 diabetes, Gall bladder disease, Dyslipidaemia, Insulin resistance, Breathlessness, Sleep apnoea |
| Moderately increased | CHD, Hypertension, Osteoarthritis (knees), Hyperuricaemia/gout |
| Slightly increased | Breast/endometrial/colon cancer, PCOS, Impaired fertility, Low back pain |
| Application | Details |
|---|---|
| Epidemiological surveys | Assess prevalence of overweight/obesity in community |
| Nutritional assessment | Classify CED (underweight) and obesity |
| Non-communicable disease risk | Screening for diabetes, HTN, CVD risk |
| Population-level monitoring | Track nutrition transition in India |
| Clinical screening | Identify individuals needing intervention |
| Cut-off for obese class III | ≥ 40 = "morbid obesity" - surgical/bariatric intervention |
| Item | Value |
|---|---|
| Formula | Weight(kg) / Height²(m²) |
| Also known as | Quetelet's Index |
| Normal BMI | 18.5 - 24.99 |
| Underweight | < 18.5 |
| Overweight (pre-obese) | 25 - 29.99 |
| Obese Class I | 30 - 34.99 |
| Obese Class II | 35 - 39.99 |
| Obese Class III (Morbid) | ≥ 40 |
| Asian/Indian overweight cut-off | ≥ 23 |
| Asian/Indian obesity cut-off | ≥ 27.5 |
| Waist circumference risk - Men | ≥ 102 cm (Asian: ≥ 90 cm) |
| Waist circumference risk - Women | ≥ 88 cm (Asian: ≥ 80 cm) |
| WHR risk - Men | > 1.0 |
| WHR risk - Women | > 0.85 |
| Skinfold sum (boys) | < 40 mm |
| Skinfold sum (girls) | < 50 mm |
| Corpulence index upper limit | 1.2 |
| BMI classification basis (WHO) | BMI vs mortality association |
BMR
"Even when a person is at complete rest, considerable energy is required to perform all the chemical reactions of the body. This minimum level of energy required to exist is called the BMR." - Guyton & Hall
| Factor | Effect | Magnitude |
|---|---|---|
| Thyroid hormone (Thyroxine) | Increases chemical reaction rates of cells | Max secretion → BMR rises 50-100% above normal |
| Male sex hormone (Testosterone) | Anabolic effect → increases skeletal muscle mass | Increases BMR 10-15% |
| Growth hormone | Stimulates cellular metabolism + skeletal muscle | Increases BMR by ~20% |
| Fever | Increases chemical reactions of body | 10-12% for every 1°C rise in temperature |
| Cold climate | Thyroid adapts → increased secretion | Arctic BMR 10-20% higher than tropical |
| Sympathetic stimulation / Adrenaline | Stimulates cellular oxidation | Increases BMR |
| Physical activity (not truly BMR but TEE) | Skeletal muscle activity | Up to 50x normal briefly |
| Pregnancy | Extra tissue deposition, fetal metabolism | +350 kcal/day |
| Lactation | Milk secretion | +600 kcal/day (0-6 months) |
| Growth (children/adolescents) | Puberty spurt | Children >13 yrs need as much as adults |
| Factor | Effect | Magnitude |
|---|---|---|
| Ageing | Loss of muscle mass, replaced by adipose tissue | 2% decline per decade in resting metabolism |
| Female sex | Lower muscle%, higher fat% vs men | Lower BMR than men at same BMI |
| Sleep | Decreased CNS activity + decreased muscle tone | 10-15% below normal |
| Malnutrition / Starvation | Paucity of food substances in cells | 20-30% decrease |
| Hypothyroidism | Loss of thyroid secretion | BMR falls to 40-60% of normal |
| Hot climate | Thyroid adapts → decreased secretion | Lower BMR |
| Advancing age after 40 | FAO/WHO: reduce by 5%/decade up to 60, then 10%/decade | Progressive fall |
| Component | Contribution | Details |
|---|---|---|
| BMR / RMR | 50-70% of TEE | Minimum energy for vital functions |
| Physical Activity | 20-30% of TEE | Most variable component |
| Thermic Effect of Food (TEF / SDA) | ~10% of TEE | Energy for digestion/absorption/metabolism of food |
| Nutrient | Energy yield |
|---|---|
| Protein | 4 kcal/g |
| Carbohydrate | 4 kcal/g |
| Fat | 9 kcal/g |
| Dietary Fibre | 2 kcal/g (fermentable only) |
| Alcohol | 7 kcal/g |
| Category | Activity | ICMR 2020 (kcal/day) | ICMR 2010 (kcal/day) |
|---|---|---|---|
| Adult Men | Sedentary | 2110 | 2320 |
| Moderate work | 2710 | 2730 | |
| Heavy work | 3470 | 3490 | |
| Adult Women | Sedentary | 1660 | 1900 |
| Moderate work | 2130 | 2230 | |
| Heavy work | 2720 | 2850 | |
| Pregnant women | - | +350 | +350 |
| Lactating (0-6 months) | - | +600 | +600 |
| Lactating (7-12 months) | - | +520 | +520 |
| Age Group | ICMR 2020 (kcal/day) |
|---|---|
| Infants 0-6 months | 550 |
| Infants 6-12 months | 670 |
| Children 1-3 years | 1010 |
| Children 4-6 years | 1360 |
| Children 7-9 years | 1700 |
| Boys 10-12 years | 2220 |
| Girls 10-12 years | 2060 |
| Boys 13-15 years | 2860 |
| Girls 13-15 years | 2400 |
| Boys 16-18 years | 3320 |
| Girls 16-18 years | 2500 |
| Item | Value |
|---|---|
| BMR definition | Minimum energy to maintain vital functions at rest |
| BMR normal (70-kg adult man) | 65-70 kcal/hour |
| BMR as % of TEE | 50-70% |
| BMR unit | kcal/hour/m² body surface area |
| Fasting before BMR test | 12 hours |
| Temperature for BMR test | 68-80°F (20-26.7°C) |
| Thyroid (max) effect on BMR | +50-100% |
| Hypothyroid effect on BMR | 40-60% of normal |
| Fever effect on BMR | +10-12% per °C |
| Sleep effect on BMR | -10-15% |
| Male sex hormone effect | +10-15% |
| Malnutrition effect on BMR | -20-30% |
| Arctic vs tropical BMR difference | 10-20% higher in Arctic |
| Age-related BMR decline | 2% per decade |
| FAO/WHO: after age 40 | Reduce energy by 5% per decade |
| FAO/WHO: after age 60 | Reduce energy by 10% per decade |
| Sedentary adult man (ICMR 2020) | 2110 kcal/day |
| Sedentary adult woman (ICMR 2020) | 1660 kcal/day |
| Extra energy in pregnancy | +350 kcal/day |
| Extra energy in lactation (0-6 m) | +600 kcal/day |
| PAR formula | Energy cost of activity / Energy cost of BMR (per minute) |